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R
heumatoid arthritis (RA)3 is a chronic inflammatory joint disease categorized as an autoimmune disorder in which autoaggressive T cells orchestrate the local inflammatory response. However, the pathogenic role of T cells in RA is incompletely understood. Although high numbers of primed CD45RO+ T cells expressing an activated phenotype accumulate in the synovium (I-@, these T cells appear to be functionally deficient. This hyporesponsiveness is reflected by the absence or low levels of T cell-derived cytokines such as IFN-7 and IL-2 at the site of inflammation (9-12). Furthermore, RA T cells show depressed in vitro responses to recall Ags (13, 14) and mitogenic stimulation (1 5-1 8), poor helper function (l9), and reduced autologous mixed lymphocyte responses (20, 21) .
Ag-dependent T cell activation is guided by signals transmitted via the TCR. Ligation of the TCR results in the activation of several receptor-associated protein tyrosine kinases, leading to tyrosine phosphorylation of specific protein substrates in the T cell (22, 23) . One of the earliest biochemical events occumng after TCR engagement is the phosphorylation of the TCR (-chain. The TCR [-chain contains three immunoreceptor tyrosine-based activation motifs (24, 25) , which, when phosphorylated, serve as docking sites for SH2 domain-containing signaling proteins. The ZAP-70 protein tyrosine kinase (26) is recruited via its SH2 domains to the tyrosine-phosphorylated TCR (-chain (25) and is thought to lead to phosphorylation and activation of phospholipase Cyl. Phospholipase Cy1 activates the phosphatidylinositol pathway, which induces a rise in intracellular Caz+ and the activation of protein kinase C (22, 23, 27) .
A recent study found that T cells from RA patients, compared with those from healthy individuals, display reduced intracellular Ca'+ responses upon CD3 stimulation, although surface expression of TClUCD3 was normal (28) . In a previous study, we showed that decreased intracellular levels of the antioxidant glutathione (GSH) are associated with hyporesponsiveness of SF T cells in RA (18) . Interestingly, decreased GSH levels within T cells have been shown to be accompanied by diminished Cazc responses (29) . Together, these data suggest that alterations in intracellular redox balance might play a role in proximal signaling and subsequently in the hyporesponsive state of SF T cells.
To investigate the molecular basis of this hyporesponsiveness of RA T cells, we analyzed the TCR-mediated tyrosine phosphorylation in peripheral blood (PB) T cells from healthy individuals and in PB and SF T cells from RA patients. Our data suggest that the hyporesponsive state of synovial T cells in RA is a direct consequence of impaired signal transduction via the TCWCD3 complex.
Materials and Methods

Patientsdcells
Patients enrolled in this study fulfilled the American College of Rheumatology revised criteria for RA (30). All patients used nonsteroidal antiinflammatory drugs. Two patients in the biochemical study were treated additionally with salazopyrine and with azathioprine and low dose prednisone, respectively. Of five other patients in flow cytometric analysis, three were treated with methotrexate. PBMC and SF mononuclear cells were obtained by Ficoll-Hypaque density gradient centrifugation and used immediately for biochemical and flow cytometric analysis. 
T cell proliferation assays
Mononuclear cells (5 X 104/well) were cultured in anti-CD3 (OKT3)-coated 96-well flat-bottom plates (Greiner) in Iscove's modified Dulbecco's culture medium supplemented with 10% FCS. Proliferation was determined by a 16-h pulse with ['Hlthymidine after 72 h of culture.
Biochemical analysis of TCR signaling
Cells were washed twice in HEPES solution (132 mM NaCI, 6 mM KCI, 1 mM MgSO,, I mM CaCI,, 1.2 mM K,HPO,, and 20 mM HEPES, pH 7.4, supplemented with 0.5% human serum albumin and 0.1% glucose) and kept on ice. Subsequently, the cells were incubated with HEPES buffer containing 10 pg/ml anti-CD3 mAb (CLB-T3.4/1) at 37°C for the indicated periods of time. Following activation the cells were rapidly pelleted and lysed in ice-cold immunoprecipitation buffer (1% Nonidet P-40 0.01 M triethanolamine-HCI, pH 7.8; 0.15 M NaCI; 5 mM EDTA; 1 mM N"-(p-tosyl)lysine chloromethyl ketone (TLCK); 0.02 mg/ml ovomucoid trypsin inhibitor; 1 mM PMSF; 0.02 mg/ml leupeptin; 0.4 mM vanadate; 10 mM NaF; 10 mM pyrophosphate; and 25 pM phenylarsine oxide). Nuclear debris was removed by centrifugation for 15 min at 13,000 rpm. Lysates were precleared with 60 pl of a 10% (vlv) suspension of protein A-CUB Sepharose beads (Pharmacia, Uppsala, Sweden) coated with normal mouse Ig. Immunoprecipitation of phosphotyrosine or TCR-( proteins with specific Abs was conducted for 2 h. Immunoprecipitates were subjected to five washes with ice-cold immunoprecipitation buffer with detergent and resuspended in reducing sample buffer. Proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes (Amersham, Aylesbury, U.K.). After blocking with 5% low fat milk suspension, reactivity with specific Abs was detected by enhanced chemiluminescence (Amersham) to visualize the bound proteins. Autoradiography was performed with Kodak X-OMAT S films (Eastman Kodak, Rochester, NY).
Flow cytometric analysis
PBMC and SFMC were fixed in 0.5% formaldehyde for 20 min at 4"C, washed twice in ice-cold PBS, and stored overnight at 4°C. Expression of (-chain was measured by an immunofluorescence assay as previously described (31), with minor modifications. In short, formaldehyde-fixed PBMC and SFMC were resuspended at a concentration of 5 X 10' cellslml in PBS-BSA containing 10 pg digitonidml (Sigma Chemical Co., St. Louis, MO) as a permeabilizing agent and incubated on ice for IO min, after which >95% of the cells were permeabilized as determined by trypan blue uptake. Next, cells were incubated in I% normal goat serum for 5 min to block aspecific binding sites, washed, and incubated with an optimal concentration of the TCR-( mAb (Coulter) for 30 min on ice. A negative control was incubated with an isotype-matched irrelevant Ab. After washing three times, cells were incubated with GAM-FITC (2 pg/ml) in PBS containing 0.05% Tween-20 for 30 min on ice. Next, free F(ab'), sites of cell-bound GAM-FITC were blocked using 1% normal mouse serum, whereafter staining was performed with anti-CD3-phycoerythrin (Leu 4) for 30 min. After washing, cells were subjected to flow cytometric analysis (FACScan. Becton Dickinson). Levels of CD3 and TCR-( are expressed as the median fluorescence intensity.
Immunohistochemistry
Stainings for TCR-( and CD3 were performed on frozen sections of synovial tissue from RA patients and of tonsillar tissue as controls, as described previously (32 cording to a three-step immunoperoxidase method. The primary Abs were incubated for 60 min. For control sections, irrelevant Abs were applied. GAM-HRP Ab was added for 30 min, followed by incubation with HRPconjugated swine anti-goat Ab for another 30 min. Ultrasensitive immunohistochemical staining was performed using biotin-labeled tyramide (33) after the GAM Ab. HRP activity was detected using hydrogen peroxide as a substrate and aminoethylcarbazole (Sigma Chemical Co.) as a dye. Slides were counterstained with Mayer's Hamalaunlosung (Merck, Darmstadt, Germany) and mounted in Kaiser's glycerol gelatin (Merck).
Results
RA SF T cells display an altered tyrosine phosphorylation pattern upon ligation of the TCR compared with PB T cells
The proliferative responses of SF T cells after TCR cross-linking were decreased compared with those of PB T cells from RA patients ( I 8). The decrease in responsiveness of SF T cells could not be overcome by increasing doses of cross-linked CD3 mAb OKT3
(up to IO pg/ml) and were not due to differences in kinetics upon stimulation (data not shown). To analyze the molecular basis for the difference in PB and SF T cell responsiveness, we examined protein tyrosine phosphorylation of RA PB and SF T cells immediately after TCR engagement. For this purpose, PB and SF mononuclear cells (PBMC and SFMC) were stimulated with CD3 mAb (CLB-T3.4/1; IO pg/ml) for 3 min. RA PB T cells revealed no major differences in intensity and pattern of tyrosine phosphorylation upon TCWCD3 ligation compared with PB T cells from healthy controls, although the levels of phosphorylation of a 29-kDa protein among PB T cell samples varied (Fig. I, lunes A-D) . In contrast, stimulated SF T cells exhibited a general reduction in tyrosine phosphoprotein levels. Strikingly, the p38 phosphoprotein was virtually absent after TCWCD3 stimulation of SF T cells compared with both control and RA PB T cells (Fig. 1, lunes E and F) . Prolonged stimulation of SF T cells with CD3 mAb for up to 10 min could not overcome the decreased level of tyrosine phosphorylation (data not shown).
TCwCD3 stimulation fails to induce complete tyrosine phosphorylation of the TCR {-chain in SF T cells
One of the earliest events of TCR-mediated signaling is tyrosine phosphorylation of the TCR {-chain. To study TCR (-chain tyrosine phosphorylation in the decreased responsiveness of RA SF T cells, we conducted phosphotyrosine Ab immunoblotting of TCR-{ protein immunoprecipitates from lysates of PBMC from healthy controls and of PBMC and SFMC from RA patients. Ligation of the TCR for 1 to 10 min is sufficient for phosphorylation of TCR-(; in peripheral T cells from healthy individuals as shown by induction of the {-chain phosphoproteins pp18 and pp21 (Fig.  2 A ) . Additionally, TCWCD3 stimulation of RA PB T cells induced detectable amounts of TCR {-chain phosphoproteins pp18 and pp21 (Fig. 2C and data not shown) . In contrast, SF T cells showed a diminished TCR {-chain phosphorylation, with a selective decrease in the appearance of the slower migrating pp21 form of phosphorylated TCR-{ (Fig.  28) . Prolonged ligation of TCW CD3 for up to 20 min could not increase levels of pp21 in RA SF T cells (Fig. 2C) . for PB and SF T cells, respectively) of RA patients. In contrast, levels of {protein in SF T cells were lower than those in PB T cells from RA patients (Fig. 3 and Table I ; n = 5; p C 0.05). Diminished expression of TCR-{ correlated with decreased proliferative responses to cross-linked CD3 mAb (Fig. 4) .
Synovial T cells express strongly decreased levels of
Next, we investigated the expression of TCR-{ in frozen sections of synovial tissue from RA patients (Fig. 5) . In a conventional three-step immunostaining protocol, TCR-{ could hardly be detected in synovial tissue, whereas clear staining was observed in tonsillar tissue, which served as a positive control for the TCR-{ Ab (Fig. 5, A and 8) . However, the use of an ultrasensitive immunohistochemical technique with biotinylated tyramide revealed that the { protein was present in the synovium (Fig. 5C) . Staining for CD3 by the conventional method revealed approximately similar intensities for synovial and tonsillar tissues (Fig. 5 , D and E) .
Discussion
Here we demonstrate that the hyporesponsive state of synovial T cells from RA patients directly correlates with impaired TCR-mediated proximal signaling events. Biochemical analysis revealed decreased overall tyrosine phosphorylation upon TCR engagement in SF T cells. In addition, virtually no detectable phosphorylated p38 was observed upon TCFUCD3 ligation. Moreover, phosphorylation of the TCR [-chain was severely diminished in SF T cells. The defective phosphorylation of TCR-[ in SF T cells was accompanied by diminished levels of detectable [ protein.
Interestingly, decreased phosphorylation of a 38-kDa protein and TCR-[ after TCFUCD3 ligation has recently been described for T cells in an anergic state (34) (35) (36) . Recent studies have suggested that a disrupted tyrosine phosphorylation network may be responsible for nonresponsiveness to Ag in tolerant T cells. Specifically, defective phosphorylation of a 38-kDa protein was shown to correlate with functional anergy in in vitro and in vivo tolerized CD4 T cells (34) . Although the identity of the 38-kDa protein is still unknown, it is possible that p38, which we describe here, is identical with the 38-kDa substrate affected in anergic T cells. In addition, the appearance of the slower migrating form of phosphorylated TCR-[, pp21, was specifically decreased compared with pp18 upon TCR ligation in anergic T cells (37, 38) . In view of these data, our findings indicate that the hyporesponsive state of RA SF T cells is reminiscent of the features of anergy as previously proposed by others (39) .
In a former study, we found a correlation between hyporesponsiveness of SF T cells in RA and decreased intracellular levels of the antioxidant GSH (1 8). These data are in line with current thinking that conditions of chronic oxidative stress markedly inhibit SF T cell function. Similar observations have been reported for T cells from HIV-infected individuals, in whom lowering intracellular levels of GSH was shown to correlate directly with reduced T cell responses (40) (41) (42) . In analogy with our data, the signaling function of TCWCD3 in T cells from HIV-infected individuals was impaired, with concomitant loss of TCR-[ expression. Moreover, it was demonstrated that reduced TCR-[ correlated with impaired T cell responses and Ca" mobilization (43, 44) . These observations suggested a close relationship between oxidative stress and TCR-[ down-regulation. Recently, further support for this hypothesis was provided by Kono et al. (4S) , who reported that reactive oxygen intermediates inhibit the effector function of melanomaspecific CTL and induce down-regulation of TCR-[. TCR-[ has been shown to play a crucial role in Ag-specific T cell activation and is believed to be the limiting factor in the assembly and surface expression of the TCWCD3 complex (46) (47) (48) (49) . Surprisingly, despite the significant decrease in [ protein levels, cell surface expression of the CD3 complex on SF T cells falls in the normal range. Several possible mechanisms can be proposed to explain the diminished levels of TCR [-chain, while maintaining normal TClUCD3 surface expression. Decreased levels of detectable [ protein could be due to loss of TCR-( as a consequence of either inhibition of synthesis or increased turnover. Based on studies with hyporesponsive T cells from tumor-bearing mice (SO), we initially hypothesized that the TCR [-chain might be replaced by FceRy in the TCFUCD3 complex of SF T cells. However, preliminary data obtained by flow cytometric analysis with FceRy mAb did not provide support for this possibility (data not shown). Alternatively, post-translational modification of the TCR-f protein may underlie the diminished detection of TCR-[ in SF T cells. Such a mechanism is proposed for decreased detection of the TCW CD3-induced signaling proteins in T cells from HIV-infected patients, which are believed to undergo a conformational change or a biochemical modification, resulting in epitope loss, under con-, ditions of an altered intracellular sulfydryl status. However, since the [-chain does not contain intracellular cysteine residues, the loss of detectable TCR-[ due to a similar mechanism is not expected (43) . Moreover, the possibility of epitope loss is unlikely, because we observed diminished TCR-[ in SF T cells using two different Abs (Table I ) (our unpublished observations). Further study of TCR composition is required to define the structural alterations of the TCWCD3 complex in SF T cells.
In conclusion, evidence is provided that T cells at the site of inflammation in RA patients display an altered TCR structure and signaling capacity. The biochemical and functional status of SF T 
